Education
About Us
Working with TipRanks
Follow Us
Cytosorbents Corp (CTSO)
NASDAQ:CTSO
Earnings Data
Report Date
May 06, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.05Last Year’s EPS
-0.12Same Quarter Last Year
Based on 1 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 31, 2025
|% Change Since: -3.00%
|Next Earnings Date:May 06, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted significant product revenue growth, healthy gross margins, and progress towards regulatory approval for DrugSorb-ATR, along with a strengthened financial position. However, challenges such as flat growth in Germany, financial restatements, and a temporary sales disruption were also noted. Overall, the positive aspects slightly outweigh the negative ones.Company Guidance
During CytoSorbents' Fourth Quarter and Full Year 2024 earnings call, the company reported significant financial growth and strategic progress. The key metrics highlighted include a 25% increase in fourth-quarter product revenue, reaching $9.2 million, and a total of $35.6 million for the year, representing a 15% year-over-year growth. Core product sales were driven by 28% growth in direct sales outside Germany and 22% growth in distributor and partner sales, though direct sales in Germany remained flat. The gross margin was maintained at a healthy 71%. The company has also made strides in regulatory processes for its DrugSorb-ATR product, with FDA acceptance of their de novo application and advanced review underway with Health Canada. Financially, the company bolstered its position with a $20 million debt facility and a successful shareholder rights offering, increasing total liquidity by $12.3 million, resulting in a pro forma cash position of approximately $17 million by the end of 2024. The company aims to reach near cash flow breakeven for its core business by the end of 2025.Strong Product Revenue Growth
CytoSorbents reported a 25% increase in fourth quarter product revenue compared to the prior year, reaching $9.2 million, and a 15% year-over-year growth in product revenue for the full year 2024, totaling $35.6 million.
Healthy Gross Margins
The product gross margin remained strong at 71%, reflecting the effectiveness of the company's razor blade business model.
Regulatory Progress for DrugSorb-ATR
Significant progress was made in bringing DrugSorb-ATR to market, with the FDA accepting the de novo application and Health Canada advancing the medical device license application. Regulatory decisions from both agencies are expected in 2025.
Financial Position Strengthened
The company's financial position was strengthened through a $20 million debt facility and a successful shareholder rights offering raising net proceeds of $7.3 million, resulting in a total liquidity increase of $12.3 million.
Successful Cost Reduction Efforts
Operating expenses decreased by 30% year-over-year in Q4, and adjusted EBITDA loss improved by 70%.
---
CTSO Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
CTSO Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Mar 31, 2025 | $1.00 | $1.00 | 0.00% |
| Nov 07, 2024 | $0.90 | $0.74 | -17.78% |
| Aug 13, 2024 | $0.90 | $0.97 | +7.78% |
| May 09, 2024 | $0.81 | $0.91 | +12.35% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Cytosorbents Corp (CTSO) report earnings?
Cytosorbents Corp (CTSO) is schdueled to report earning on May 06, 2025, TBA Not Confirmed.
What is Cytosorbents Corp (CTSO) earnings time?
Cytosorbents Corp (CTSO) earnings time is at May 06, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is CTSO EPS forecast?
CTSO EPS forecast for the fiscal quarter 2025 (Q1) is -0.05.
---